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1 General information 
 
All chemicals used for synthesis were purchased from commercial sources and were used without further 
purification. All solvents were purified by distillation using rotary evaporation or were purchased in 
HPLC-grade-quality. All products were dried in high vacuum (up to 10-3 bar). Thin layer 
chromatography (TLC) was performed on pre-coated aluminum sheets ALUGRAM® SIL G/UV254 (0.2 
mm silica gel with fluorescent indicator, MachereyNagel & Co).1H-NMR (13C-NMR) spectra were 
recorded at room temperature on a Bruker Avance 300 or 400 or JEOL JNM GX 400 spectrometer 
operating at 300 MHz or 400 MHz. All chemical shifts are given in the ppm-scale and refer to the non-
deuterized proportion of the solvent. ESI and APPI mass spectra were recorded on a Bruker Daltonik 
maXis 4G or a Bruker Daltonik micrOTOF II focus. IR spectra were recorded on a Varian IR-660 
apparatus. The absorption is indicated in wave numbers [cm-1]. Elemental Analysis (C, H, N), carried 
out with an Elementar vario MICRO cube machine, is within ±0.40% of the calculated values 
confirming a purity of >95%. X-Ray crystallography was performed on a SuperNova, Dual, Cu at zero, 
Atlas diffractometer. 
2 
2 General synthetic procedure and characterizations of domino products 
 
2.1 General procedure for the domino reaction 
Aldehyde (0.24 mmol), malononitrile (24 mg, 0.36 mmol) and the appropriate catalyst (0.018 mmol) 
were dissolved in toluene (caldehyde = 0.48 mol/L). The reaction mixture was stirred at room temperature 
until malononitrile was completely consumed. By evaporation of the solvent the reaction was stopped. 
The crude product was purified by silica gel column chromatography (hexane/ethyl acetate = 5/1 to 3/1). 
 
2.2 Characterization of domino products 
(1R,4R,8S)-5-amino-8-benzyl-3-(dicyanomethylene)-7-phenyl-2-azabicyclo[2.2.2]oct-5-ene-4,6-
dicarbonitrile 3a (dr >99:1, 3a':3a'') 
Isoquinuclidine anti-3a'was obtained as white solid. Elem. anal.: Found: C, 
74.64; H, 4.51; N, 20.91. Calcd for C25H18N6: C, 74.61; H, 4.51; N, 20.88%. 1H-
NMR (300 MHz, CD3OD): δ = 2.40 (dd, J1 = 12.0 Hz, J2 = 12.8 Hz, 1H), 3.06 
(dd, J1 = 1.8 Hz, J2 = 4.5 Hz, 1H), 3.15 (dt, J1 = 4.1 Hz, J2 = 11.7 Hz, 1H), 3.53 
(dd, J1 = 3.7 Hz, J2 = 13.0 Hz, 1H), 4.18 (d, J = 1.9 Hz, 1H), 6.75-6.78 (m, 2H), 6.97-7.14 ppm (m, 8H). 
13C-NMR (100 MHz, CD3OD): δ =39.9, 49.7, 50.0, 53.3, 53.9, 58.0, 77.1, 113.6, 116.5, 127.9, 128.2, 
128.7, 129.5, 129.6, 130.6, 137.7, 141.1, 154.3, 163.9 ppm. IR(ATR, solid) /cm-1: 3457, 3321, 3267, 
3220, 3063, 2937, 2201, 1659, 1604, 1563, 1497, 1296, 1215, 986, 730, 713, 702, 589, 540. MS 
(MALDI) m/z = 403 ([M+H]+), 425 ([M+Na]+), 441 ([M+K]+). HRMS (ESI) calcd for (C25H18N6Na+): 
425.1485; found: m/z = 425.1490 ([M+Na]+). 
 
(1S,4S)-6-amino-7-benzyl-2-imino-8-phenylbicyclo[2.2.2]oct-5-ene-1,3,3,5-tetracarbonitrile 4a 
(two diastereomers, dr 46:54) 
Compound 4a (carbobicycle) was obtained as white solid. Elem. anal.: Found: 
C, 74.36; H, 4.62; N, 20.55. Calcd for C25H18N6: C, 74.61; H, 4.51; N, 20.88%. 
1H-NMR (300 MHz, (CD3)2CO): δ = 2.41-2.58 (m, 2H), 3.36-3.49 (m, 6H), 3.79-
3.85 (1×d, 1×s, 2×1H), 6.91-7.14 (m, 24H), 12.10-12.89 ppm (2×s, 2×1H). 13C-
NMR (100 MHz, (CD3)2CO): δ = 39.7, 43.2, 44.5, 46.5, 47.7, 48.6, 48.8, 49.0, 57.1, 58.8, 70.2, 70.8, 
113.0, 113.3, 113.5, 113.9, 114.3, 116.8, 116.9, 127.8, 127.9, 128.2, 128.2, 128.6, 128.6, 129.3, 129.3, 
129.3, 129.6, 130.2, 130.2, 137.2, 137.4, 141.3, 141.4, 155.3, 156.4, 160.7, 161.9 ppm. IR(ATR, solid) 
/cm-1: 3441, 3354, 3263, 3211, 3030, 2920, 2361, 2197, 1639, 1605, 1493, 1454, 1314, 1224, 967, 918, 
843, 764, 734, 696, 557, 514. MS (MALDI) m/z = 425 ([M+Na]+). HRMS (ESI) calcd for 




dicarbonitrile 3b' (dr38:62, 3b': 3b'') 
Isoquinuclidine anti-3b' was obtained as white solid. 1H-NMR (400 MHz, 
CD3OD): δ = 1.04 (t, J = 7.3 Hz, 3H), 1.06 (d, J = 6.8 Hz, 3H), 1.13-1.21 (m, 1H), 
1.72 (ddd, J1 = 3.2 Hz, J2 = 4.0 Hz, J3 = 11.4 Hz), 1.84-1.91 (m, 1H), 1.98-2.08 (m, 
1H), 4.18 ppm (d, J = 2.0 Hz, 1H).13C-NMR (100 MHz, CD3OD): δ = 11.5, 20.4, 26.9, 42.5, 48.0, 51.5, 
53.0, 57.5, 76.8, 113.9, 115.6, 115.6, 116.7, 154.2, 164.0 ppm. IR(ATR, solid) /cm-1: 3404, 3335, 3287, 
3268, 3209, 3135, 2972, 2934, 2918, 2892, 2879, 2223, 2195, 1649, 1611, 1582, 1455, 1437, 1403, 
1293, 1229, 1206, 1104, 1029, 976, 933, 872, 788, 721. MS (MALDI) m/z = 301 ([M+Na]+). HRMS 




Isoquinuclidine syn-3b'' was obtained as white solid. 1H-NMR (300 MHz, 
CD3OD): δ = 1.06-1.13 (m, 6H), 1.46-1.61 (m, 1H), 1.82-1.95 (m, 1H), 2.31 (ddd, 
J1 = 2.4 Hz, J2 = 10.1 Hz, J3 = 10.3 Hz), 2.38-2.49 (m, 1H), 4.20 ppm (d, J = 1.8 
Hz, 1H). 13C-NMR (100 MHz, CD3OD): δ = 14.6, 15.1, 22.7, 38.7, 48.1, 50.3, 
54.2, 58.4, 76.9, 114.8, 116.6, 156.5, 162.5 ppm. IR(ATR, solid) /cm-1: 3448, 3359, 3290, 3008, 2938, 
2187, 1651, 1605, 1564, 1461, 1397, 1385, 1296, 1206, 1039, 972, 752, 588, 519, 433. HRMS (APPI) 
calcd for (C15H15N6+): 279.1353; found: m/z = 279.1350 ([M+H]+). 
 
(1S,4S)-6-amino-7-ethyl-2-imino-8-methylbicyclo[2.2.2]oct-5-ene-1,3,3,5-tetracarbonitrile 4b 
Compound 4b (carbobicycle) was obtained as white solid. 1H-NMR (400 MHz, 
(CD3)2CO): δ = 1.06-1.09 (m, 1H), 1.11-1.17 (m, 7H), 1.23-1.25 (m, 7H), 1.48 (dd, 
J1 = 1.6 Hz, J2 = 7.2 Hz, 2H), 1.84-1.99 (m, 5H), 2.10-2.30 (m, 3H), 3.68-3.87 (2×d, 
2×s, 4×1H), 11.59-12.60 ppm (4×s, 4×1H). MS (MALDI) m/z = 301 ([M+Na]+). HRMS (ESI) calcd for 













5-ene-4,6-dicarbonitrile 3c (dr >99:1) 
Isoquinuclidine 3c was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.15 (s, 3H), 2.20 (s, 3H), 2.50 (t, J = 12.3 Hz, 1H), 
3.26(dd,J1 = 1.7 Hz, J2 = 4.2 Hz,1H), 3.35-3.42 (m, 1H), 3.50 (dd, J1 = 3.2 
Hz, J2 = 13.0 Hz, 1H), 4.39 (d, J = 1.5 Hz, 1H), 6.85-6.96 (m, 8H), 7.10 (d, 
J = 7.8 Hz, 2H), 9.28 ppm (brs, 1H). 13C-NMR (75 MHz, (CD3)2CO): δ = 20.6, 21.1, 39.9, 50.7, 53.1, 
57.1, 57.3, 58.9, 78.3, 113.3, 113.6, 115.3, 116.0, 127.9, 129.2, 129.9, 130.5, 130.9, 134.6, 137.0, 137.3, 
138.0, 153.2, 163.1 ppm. MS (MALDI) m/z = 453 ([M+Na]+). HRMS (ESI) calcd for (C27H22N6Na): 
453.1798; found: m/z = 453.1799 ([M+Na]+).  
 
6-amino-2-imino-7-(4-methylbenzyl)-8-(p-tolyl)bicyclo[2.2.2]oct-5-ene-1,3,3,5-tetracarbonitrile 
4c (two diastereomers, dr 47:53) 
Compound 4c (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO):δ = 2.17 (2×s, 6H), 2.22 (2×s, 6H), 2.38-2.53 (m, 
2H), 3.29-3.42 (m, 6H), 3.74-3.81 (1×d, 1×s, 2×1H), 6.80-6.83 (m, 4H), 
6.89-7.03 (m, 16H), 12.06-12.85 ppm (2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 20.7, 21.9, 
22.1, 23.8, 40.3, 44.1, 45.4, 47.1, 48.8, 49.7, 49.9, 50.1, 58.1, 59.8, 71.3, 71.9, 114.1, 114.3, 114.5, 
114.9, 115.0, 115.3, 117.8, 117.9, 129.5, 129.5, 130.9, 130.9, 130.9, 130.9, 131.1, 131.1, 135.1, 135.4, 
138.2, 138.4, 138.7, 138.8, 139.4, 139.5, 156.2, 157.3, 161.8, 162.9 ppm. MS (MALDI) m/z = 453 
([M+Na]+). HRMS (ESI) calcd for (C27H22N6Na):453.1798; found: m/z = 453.1794 ([M+Na]+). 
 
(1R,4R,8S)-5-amino-3-(dicyanomethylene)-7-(naphthalen-2-yl)-8-(naphthalen-2-ylmethyl)-2-
azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3d (dr >99:1) 
Isoquinuclidine 3d was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.84 (dd, J1 = 12.7 Hz, J2 = 13.2 Hz, 1H), 3.60-3.61 (m, 1H,) 
3.76-3.81 (m, 2H), 4.54 (d, J = 1.8 Hz, 1H), 6.99 (s, 2H), 7.07-7.11 (m, 1H), 
7.34-7.39 (m, 5H), 7.45-7.48 (m, 2H), 7.51-7.61 (m, 3H), 7.67-7.69 (m, 2H), 
7.83 (s, 1H), 9.34 ppm (brs, 1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 40.9, 49.6, 51.9, 54.0, 54.4, 58.7, 
79.4, 114.3, 115.7, 116.2, 116.9, 127.5, 127.8, 127.9, 127.9, 128.4, 129.2, 129.2, 129.4, 129.7, 129.8, 
130.3, 134.3, 134.4, 135.2, 135.4, 136.2, 139.3, 154.3, 164.1 ppm. MS (MALDI) m/z = 525 ([M+Na]+). 







1,3,3,5-tetracarbonitrile 4d (two diastereomers, dr 45:55) 
Compound 4d (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO):δ =  2.69-2.80 (m, 2H), 3.57-3.69 (m, 6H), 3.92-3.99 
(1×d, 1×s, 2×1H), 7.06-7.27 (m, 7H), 7.33-7.44 (m, 13H), 7.55-7.73 (m, 
11H), 12.19-12.96 ppm (2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 
41.0, 41.0, 43.8, 44.2, 44.3, 45.6, 47.8, 47.8, 48.7, 49.5, 49.5, 49.6, 58.2, 59.9, 
71.3, 71.9, 114.0, 114.4, 114.5, 114.9, 115.0, 115.4, 117.8, 117.9, 127.2, 127.3, 127.6, 127.7, 127.9, 
128.0, 128.0, 128.0, 128.1, 128.9, 129.0, 129.3, 129.3, 129.3, 129.4, 129.6, 129.6, 129.9, 130.0, 130.0, 
130.1, 130.1, 130.2, 130.9, 134.4, 134.4, 135.0, 135.3, 135.8, 136.1, 139.5, 139.6, 156.4, 157.5, 161.8, 
162.9 ppm. MS (MALDI) m/z = 525 ([M+Na]+). HRMS (ESI) calcd for (C33H22N6Na): 525.1798; found: 
m/z = 525. 1793 ([M+Na]+). 
 
(1R,4R,8S)-5-amino-8-(4-bromobenzyl)-7-(4-bromophenyl)-3-(dicyanomethylene)-2-azabicycle 
[2.2.2]oct-5-ene-4,6-dicarbonitrile 3e (dr >99:1) 
Isoquinuclidine 3e was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.57 (t, J = 12.0 Hz,1H), 3.30 (dd, J1 = 1.5 Hz, J2 = 4.6 Hz, 
1H), 3.46-3.56 (m, 2H), 4.43 (d, J = 1.8 Hz, 1H), 6.91-6.99 (m, 4H), 7.21-
7.28 (m, 4H), 7.33(m, 2H), 9.30 ppm (brs, 1H). 13C-NMR (100 MHz, 
(CD3)2CO): δ = 39.7, 49.3, 52.1, 53.6, 53.6, 58.3, 79.4, 114.0, 114.3, 116.7, 119.7, 122.2, 122.5, 131.8, 
133.2, 133.2, 133.6, 138.0, 141.2, 153.8, 164.0 ppm. IR(ATR, solid) /cm-1: 3434, 3335, 3203, 2922, 
2201, 1649, 1569, 1488, 1405, 1295, 1217, 1072, 1009, 819, 702, 662, 515. MS (MALDI) m/z= 583 
([M+Na]+). HRMS (ESI) calcd for (C25H16Br2N6Na): 580.9695, found: m/z = 580.9708 ([M+Na]+). 
 
(1S,4S)-6-amino-7-(4-bromobenzyl)-8-(4-bromophenyl)-2-iminobicyclo[2.2.2]oct-5-ene-1,3,3,5-
tetracarbonitrile 4e (two diastereomers, dr 47:53) 
Compound 4e (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO): δ = 2.42-2.57 (m, 2H), 3.35-3.47 (m, 6H), 3.80-3.87 
(1×d, 1×s, 2×1H), 6.84-6.94 (m, 6H), 6.97-7.07 (m, 10H), 7.16-7.22 (m, 4H), 
12.12-12.90 ppm (2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 39.8, 
39.9, 43.1, 45.5, 47.1, 47.2, 48.4, 49.2, 49.6, 49.8, 58.0, 59.6, 70.5, 71.1, 113.8, 114.0, 114.3, 114.6, 
114.7, 115.2, 117.7, 122.5, 122.5, 122.9, 122.9, 123.0, 131.7, 131.7, 132.5, 133.2, 133.3, 133.3, 133.4, 
133.4, 133.5, 137.6, 137.8, 141.5, 141.6, 156.5, 157.6, 161.4, 162.5ppm. IR(ATR, solid) /cm-1: 3437, 
3335, 3206, 2922, 2202, 1649, 1569, 1488, 1405, 1294, 1216, 1072, 1009, 819, 702, 662, 544. MS 













azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3f (dr >99:1) 
Isoquinuclidine 3f was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.57 (t, J = 13.3 Hz, 1H), 3.30 (dd, J1 = 1.6 Hz, J2 = 4.8 Hz, 
1H), 3.52-3.61 (m, 2H),4.48 (d, J = 1.8 Hz, 1H), 6.91 (s, 2H), 6.99-7.13 (m, 
4H), 7.22-7.31 (m, 3H), 7.49 (s, 1H) 9.34 ppm (brs, 1H).13C-NMR (75 MHz, 
(CD3)2CO): δ = 38.9, 52.2, 53.6, 54.3, 57.2, 59.0, 79.7, 113.8, 116.4, 116.8, 123.7, 123.7, 123.8, 131.2, 
131.4, 131.5, 131.7, 132.0, 132.3, 132.4, 132.6, 134.4, 141.1, 144.3, 153.6, 163.9 ppm. MS (MALDI) 




tetracarbonitrile 4f (two diastereomers, dr 46:54) 
Compound 4f (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO): δ = 2.40-2.57 (m, 2H), 3.27-3.29 (m, 2H), 3.41-3.56 
(m, 4H), 3.89-3.96 (1×d, 1×s, 2×1H), 7.05-7.37 (m, 22H), 12.16-12.93 ppm 
(2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 39.8, 39.9, 44.4, 45.7, 
47.4, 48.3, 49.1, 49.6, 49.7, 70.4, 71.0, 113.8, 114.0, 114.3, 114.5, 114.7, 115.1, 117.7, 117.8, 123.9, 
123.9, 124.0, 124.1, 128.4, 130.3, 130.3, 132.0, 132.1, 132.2, 132.2, 132.2, 132.5, 132.5, 132.8, 132.9, 
134.2, 134.3, 140.8, 141.1, 144.6, 144.7, 156.6, 157.7, 161.4, 162.5 ppm. MS (MALDI) m/z = 583 
([M+Na]+). HRMS (APPI) calcd for (C25H17Br2N6): 558.9876; found: m/z = 558.9871 ([M+H]+). 
 
(1R,4R,8S)-5-amino-3-(dicyanomethylene)-8-(4-fluorobenzyl)-7-(4-fluorophenyl)-2-
azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile3g (dr >99:1) 
Isoquinuclidine 3g was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.56 (t, J = 12.0 Hz, 1H), 3.29 (dd, J1 = 1.6 Hz, J2 = 4.7 Hz, 
1H), 3.40-3.47 (m, 1H), 3.55 (dd, J1 = 3.6 Hz, J2 = 12.8 Hz, 1H), 4.40 (d, J = 
1.8 Hz, 1H), 6.80-6.92 (m, 6H), 6.99-7.04 (m, 2H), 7.25-7.30 (m, 2H), 9.30 
ppm (brs, 1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 39.5, 49.9, 52.0, 53.5, 53.7, 53.7, 58.5, 79.6, 79.6, 
114.0, 114.4, 116.2, 116.2, 116.7 (d, JC-F = 4.9 Hz), 116.8, 116.9 (d, JC-F = 4.8 Hz), 131.6 (d, JC-F = 8.2 
Hz), 133.3 (d, JC-F = 8.0 Hz), 134.7 (d, JC-F = 3.2 Hz), 138.0 (d, JC-F = 3.2 Hz), 153.9 (d, JC-F = 6.6 Hz), 
162.5, 164.2, 164.9 ppm. IR(ATR, solid) /cm-1: 3440, 3342, 3225, 2923, 2202, 2026, 1987, 1649, 1570, 
1511, 1440, 1296, 1224, 1160, 1101, 1013, 831, 762, 689, 533. MS (MALDI) m/z = 461 ([M+Na]+). 





















tetracarbonitrile 4g (two diastereomers, dr 47:53) 
Compound 4g (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO): δ = 2.40-2.56 (m, 2H), 3.33-3.46 (m, 6H), 3.79-3.86 
(1×d, 1×s, 2×1H), 6.83-7.10 (m, 16H), 7.15-7.21 (m, 4H), 12.12-12.90 ppm 
(2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 39.6, 44.2, 45.5, 46.9, 
48.6, 49.5, 50.1, 50.2, 59.6, 70.7, 71.3, 113.8, 114.0, 114.6, 114.7, 115.1, 116.8 (q, J1C-F = 2.4 Hz, J2C-F 
= 3.8 Hz), 117.0 (q, J1C-F = 2.4 Hz, J2C-F = 3.8 Hz), 117.7, 131.5 (q, J1C-F = 1.7 Hz, J2C-F = 8.3 Hz), 133.0 
(q, J1C-F = 1.3 Hz, J2C-F = 8.1 Hz), 134.2 (d, JC-F = 3.2 Hz), 134.4 (d, JC-F = 3.2 Hz), 138.2 (d, JC-F = 3.1 
Hz), 138.3 (d, JC-F = 3.1 Hz), 156.3 (d, JC-F = 6.7 Hz), 157.4, 161.4, 162.5, 165.0 ppm. IR(ATR, solid) 
/cm-1: 3425, 3334, 3204, 2958, 2835, 2201, 2050, 1649, 1608, 1570, 1512, 1459, 1393, 1246, 1178, 
1114, 1029, 827, 775, 546. MS (MALDI) m/z = 461 ([M+Na]+). HRMS (ESI) calcd for (C25H16F2N6Na): 




Isoquinuclidine 3h was obtained as white solid. 1H-NMR (400 MHz, 
(CD3)2SO): δ = 2.20 (t, J = 12.5 Hz, 1H), 2.90 (d, J = 2.8 Hz, 1H), 3.27-3.28 
(m, 2H), 3.40 (s, 3H), 3.61 (s, 3H), 3.64 (s, 3H), 3.67 (s, 3H), 4.08 (d, J = 
1.1 Hz, 1H), 6.36-6.41 (m, 2H), 6.64-6.71 (m, 4H), 7.40 (s, 2H), 10.65 ppm 
(bs, 1H). 13C-NMR (100 MHz, (CD3)2SO): δ = 37.9, 47.1, 51.2, 51.6, 55.0, 
55.1, 55.4, 55.5, 56.6, 74.7, 111.3, 111.4, 111.4, 112.5, 112.9, 113.7, 115.3, 116.2, 119.4, 121.4, 128.8, 
132.8, 147.3, 147.4, 148.1, 148.4, 152.6, 161.9 ppm. IR(ATR, solid) /cm-1: 3735, 3471, 3378, 3228, 
2933, 2834, 2362, 2197, 1647, 1582, 1515, 1557, 1416, 1263, 1253, 1145, 1023, 797, 764, 661, 610, 
552. MS (MALDI) m/z = 545 ([M+Na]+). HRMS (ESI) calcd for (C29H26N6NaO4+): 545.1908; found: 




Compound 4h (carbobicycle) was obtained as white solid. 1H-NMR (400 
MHz, (CD3)2CO): δ = 2.12-2.15 (m, 1H), 2.31-2.45 (m, 2H), 3.26-3.34 (m, 
3H), 3.47 (s, 3H), 3.47 (s, 3H), 3.69 (s, 3H), 3.69 (s, 3H), 3.70 (s, 3H), 3.72 
(s, 3H), 3.80-3.81 (m, 2H), 6.42-6.47 (m, 4H), 6.67-6.74 (m, 8H), 6.94-6.99 






azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3i (dr >99:1) 
Isoquinuclidine 3i was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.47 (t, J = 12.3 Hz, 1H), 3.21-3.22 (m, 1H), 3.28-3.34 (m, 
1H), 3.50 (dd, J1 = 3.2 Hz, J2 = 13.0 Hz, 1H), 4.36 (d, J = 1.1 Hz, 1H), 6.62-
6.70 (m, 4H), 6.85-6.90 (m, 4H), 7.13 (d, J = 8.4 Hz, 2H), 9.31 ppm (brs, 1H). 
13C-NMR (100 MHz, (CD3)2CO): δ = 39.7, 50.2, 51.5, 53.4, 53.9, 56.4, 56.5, 
58.9, 79.3, 114.2, 115.5, 115.6, 116.9, 119.7, 130.4, 130.7, 132.4, 133.9, 154.0, 154.1, 160.6, 160.7, 
164.2 ppm. IR(ATR, solid) /cm-1: 3443, 3337, 3212, 2933, 2836, 2360, 2200, 1650, 1608, 1570, 1512, 
1459, 1396, 1247, 1179, 1115, 1029, 830, 753, 547. MS (MALDI) m/z = 485 ([M+Na]+). HRMS (ESI) 
calcd for (C27H22N6O2Na+): 485.1697; found: m/z = 485.1689 ([M+Na]+). 
 
(1S,4S)-6-amino-2-imino-7-(4-methoxybenzyl)-8-(4-methoxyphenyl)bicyclo[2.2.2]oct-5-ene-
1,3,3,5-tetracarbonitrile 4i (two diastereomers, dr 50:50) 
Compound 4i (carbobicycle) was obtained as white solid. 1H-NMR 
(300 MHz, (CD3)2CO): δ = 2.40-2.51 (m, 2H), 3.23-3.40 (m, 6H), 3.68 
(s,6H), 3.72 (s, 6H), 3.79-3.80 (1×d, 1×s, 2×1H), 6.63-6.72 (m, 8H), 6.85-
6.99 (m, 8H), 7.03-7.06 (m, 4H), 12.04-12.83 ppm (2×s, 2×1H). 13C-NMR 
(100 MHz, (CD3)2CO): δ = 39.8, 39.8, 46.7, 48.4, 48.5, 48.9, 49.7, 50.2, 50.3, 50.4, 56.5, 56.5, 59.8, 
59.8, 71.3, 71.9, 114.1, 114.3, 115.0, 115.3, 115.6, 115.7, 115.8, 130.0, 130.3, 130.7, 130.7, 131.7, 
132.2, 132.2, 134.4, 134.5, 138.0, 157.5, 157.5, 160.8, 160.9, 160.9, 160.9 ppm. IR(ATR, solid) /cm-1: 
3426, 3333, 3206, 2957, 2835, 2200, 2042, 1648, 1607, 1569, 1511, 1458, 1393, 1299, 1246, 1178, 
1114, 1029, 826, 775, 544. MS (MALDI) m/z = 485 ([M+Na]+). HRMS (ESI) calcd for 
(C27H22N6O2Na+): 485.1697; found: m/z = 485.1689([M+Na]+). 
 
(1R,4R,8S)-5-amino-3-(dicyanomethylene)-7-(thiophen-2-yl)-8-(thiophen-2-ylmethyl)-2-
azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3j (dr >99:1) 
Isoquinuclidine 3j was obtained as white solid. 1H-NMR (300 MHz, (CD3)2CO): 
δ = 2.94 (dd, J1 = 11.8 Hz, J2 = 13.9 Hz, 1H), 3.19-3.25 (m, 1H), 3.65-3.72 (m, 
2H), 4.58 (d, J = 2.0 Hz, 1H), 6.64 (d, J = 3.3 Hz, 1H), 6.80 (dd, J1 = 3.6 Hz, J2 
= 5.1 Hz, 1H), 6.85 (dd, J1 = 3.5 Hz, J2 = 5.1 Hz, 1H), 6.89 (brs, 1H), 7.02 (d, J 
= 3.3 Hz, 1H), 7.20-7.24 (m, 2H), 9.46 ppm (brs, 1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 34.6, 49.5, 
52.1, 52.8, 53.4, 58.4, 78.9, 113.9, 113.9, 114.3, 116.7, 126.6, 127.1, 127.5, 128.6, 128.8, 129.5, 140.2, 
145.2, 153.8, 163.7 ppm. IR(ATR, solid) /cm-1: 3442, 3347, 3201, 2200, 1649, 1567, 1409, 1300, 1220, 
1010, 944, 829, 689, 497. MS (MALDI) m/z = 437 ([M+Na]+). HRMS (ESI) calcd for (C21H14N6S2Na+): 



















1,3,3,5-tetracarbonitrile 4j (two diastereomers, dr 50:50) 
Compound 4j (carbobicycle) was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 2.25-2.27 (m, 2H), 3.12-3.14 (m, 2H), 3.49-3.62 (s, 2H), 3.83-
3.86 (m, 2H), 3.98-4.05 (1×d, 1×s, 2×1H), 6.52-6.54 (m, 2H), 6.78-681 (m, 2H), 
6.88-6.90 (m, 2H), 6.95-6.96 (m, 2H), 6.98-7.01 (m, 2H), 7.06-7.07 (m, 2H), 7.24-
7.30 (m, 2H), 12.11-12.92 ppm (2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 31.2, 34.2, 49.1, 
51.7, 52.3, 52.4, 53.0, 53.1, 58.0, 67.5, 71.3, 78.5, 78.5, 113.5, 113.8, 113.9, 115.8, 115.8, 116.3, 126.1, 
126.2, 126.5, 126.5, 126.7, 127.1, 128.0, 128.2, 128.4, 129.1, 139.8, 139.8, 144.8, 153.3, 153.4, 163.3, 
163.3 ppm. IR(ATR, solid) /cm-1: 3435, 3345, 3248, 3199, 2919, 2851, 2199, 1719, 1647, 1601, 1566, 
1460, 1409, 1258, 1221, 1076, 1016, 799, 685, 616, 585, 486. MS (MALDI) m/z = 437 ([M+Na]+). 





i]isochromen-10-yl)oxy)methyl)-2-azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3k (dr >75:25) 
Isoquinuclidine 3k was obtained as white solid. 1H-NMR (300 MHz, 
(CD3)2CO): δ = 0.89-0.96 (m, 18H), 1.0-1.03 (m, 6H), 1.10-1.33 (m, 
15H), 1.42-1.48 (m, 8H), 1.61-1.85 (m, 12H), 2.24-2.33 (m, 3H), 
2.60-2.62 (m, 3H), 3.48-3.66 (m, 2H), 3.71-3.98 (m, 3H), 4.28-4.44 
(m, 4H), 4.78-4.91 (m, 3H), 5.49-5.58 (m, 3H), 6.44-6.86 ppm (m, 
4H). 13C-NMR (100 MHz, CDCl3): δ =12.5, 12.8, 13.0, 20.2, 20.3, 
24.4, 24.7, 24.9, 25.0, 25.9, 26.0, 30.3, 30.5, 30.5, 30.7, 31.4, 34.3, 
34.5, 36.0, 36.2, 36.2, 37.1, 37.5, 37.5, 37.6, 39.0, 42.7, 43.6, 44.0, 52.4, 52.4, 65.6, 66.2, 74.5, 80.5, 
80.6, 87.7, 88.0, 101.8, 103.4, 104.4, 104.4, 111.7, 113.0, 114.4, 115.9, 148.3 ppm. MS (MALDI) m/z 








yl)oxy)methyl)bicyclo[2.2.2]oct-5-ene-1,3,3,5-tetracarbonitrile 4k (two diastereomers, dr 51:49) 
Compound 4k (carbobicycle) was obtained as white solid. 1H-NMR (300 
MHz, (CD3)2CO):δ = 0.94-0.98 (m, 25H), 1.01-1.06 (m, 8H), 1.20-1.27 
(m, 5H), 1.31-1.32 (m, 16H), 1.43-1.47 (m, 15H), 6.60-6.69 (m, 6H), 
1.74-1.87 (m, 14H), 2.23-2.29 (m, 5H), 2.61-2.63 (m, 5H), 3.43-3.53 (m, 
2H), 3.63-3.72 (m, 2H), 3.71-3.94 (m, 4H), 4.19-4.35 (m, 4H), 4.41-4.55 
(m, 2H), 4.87-4.90 (m, 4H), 5.37-5.49 (m, 4H), 6.42-6.71 ppm (2×s, 
2×2H). 13C-NMR (100 MHz, (CD3)2CO): δ = 14.1, 14.2, 14.2, 21.6, 21.6, 
21.7, 26.5, 26.5, 27.1, 32.6, 32.6, 32.7, 32.9, 36.3, 36.4, 36.4, 37.3, 38.1, 38.6, 38.7, 38.8, 38.9, 39.0, 
39.0, 39.0, 41.0, 43.2, 44.1, 46.0, 46.1, 46.1, 46.2, 46.2, 54.4, 54.5, 68.0, 68.1, 69.8, 70.0, 74.0, 74.0, 
74.1, 82.4, 82.5, 89.7, 89.8, 89.9, 90.0, 104.5, 105.0, 105.2, 105.6, 105.6, 105.7, 114.8, 114.8, 114.8, 
115.2, 115.2, 115.9, 117.8, 118.8, 152.1 ppm. MS (MALDI) m/z = 837 ([M+Na]+). HRMS (ESI) calcd 




i]isochromen-10-yl)oxy)phenyl)-2-azabicyclo[2.2.2]oct-5-ene-4,6-dicarbonitrile 3l (dr >90:10) 
Isoquinuclidine 3l was obtained as white solid. Elem. anal.: 
Found: C, 67.48; H, 6.65; N, 8.17. Calcd for C55H64N6O11: C, 
67.06; H, 6.55; N, 8.53%. 1H-NMR (300 MHz, (CD3)2CO): δ = 
0.94-0.98 (m, 6H), 1.0-1.03 (m, 6H), 1.21-1.24 (m, 2H), 1.31-
1.33 (m, 6H), 1.40-1.55 (m, 7H), 1.65-1.71 (m, 2H), 1.85-1.91 
(m, 6H), 2.23-2.34  (m, 2H), 2.46-2.56 (m, 1H), 2.62-2.72 (m, 
2H), 3.25-3.28 (m, 1H), 3.30-3.39 (m, 1H), 3.52 (dd, J1 = 3.2 Hz, 
J2 = 13.0 Hz, 1H), 4.41 (s, 1H), 5.28-5.43 (m, 4H), 6.83-6.90 (m, 8H), 7.16-7.20 (m, 3H), 9.37 ppm (brs, 
1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 14.2, 14.2, 14.3, 14.5, 15.3, 21.6, 21.7, 26.1, 26.1, 26.2, 26.2, 
26.4, 26.5, 27.1, 27.2, 32.7, 32.7, 32.8, 33.6, 36.4, 38.1, 38.1, 39.0, 39.1, 39.8, 46.2, 46.3, 56.4, 50.5, 
51.5, 53.1, 53.4, 53.6, 53.9, 54.5, 58.7, 58.8, 79.5, 82.4, 82.4, 89.9, 89.9, 89.9, 101.9, 101.9, 102.1, 
103.1, 105.6, 105.7, 105.7, 105.8, 118.5, 118.6, 119.0, 119.4, 131.9, 132.3, 132.5, 132.5, 135.4, 135.5, 
154.0, 154.1, 154.1, 158.4, 158.5, 158.5, 158.9, 164.2 ppm. MS (MALDI) m/z = 990 ([M+Na]+). HRMS 






















i]isochromen-10-yl)oxy)phenyl)bicyclo[2.2.2]oct-5-ene-1,3,3,5-tetracarbonitrile 4l  
(two diastereomers, dr 46:54) 
Compound 4l (carbobicycle) was obtained as white solid. Elem. 
anal.: Found: C, 67.47; H, 6.72; N, 8.04. Calcd for C55H64N6O11: 
C, 67.06; H, 6.55; N, 8.53%. 1H-NMR (300 MHz, (CD3)2CO): δ = 
0.95-0.97 (m, 12H), 1.0-1.03 (m, 12H), 1.29-1.32 (m, 22H), 1.42-
1.57 (m, 15H), 1.67-1.72 (m, 5H), 1.84-1.92 (m, 11H), 2.24-2.29 
(m, 4H), 2.34-2.54  (m, 2H), 2.67-2.71 (m, 6H), 3.15-3.42 (m, 6H), 
3.75-3.87 (m, 2H), 5.31-5.50 (m, 8H), 6.83-7.33 (m, 20H), 12.06-
12.85 ppm (2×s, 2×1H). 13C-NMR (100 MHz, (CD3)2CO): δ = 14.2, 14.2, 14.3, 14.3, 15.5, 21.6, 21.7, 
23.9, 26.1, 26.2, 26.4, 26.5, 26.6, 27.1, 27.1, 27.2, 32.7, 32.7, 32.8, 36.4, 38.0, 38.1, 38.1, 38.9, 39.0, 
39.0, 39.2, 46.6, 46.7, 46.9, 46.9, 48.5, 49.4, 50.8, 50.9, 54.5, 54.5, 56.0, 71.3, 82.4, 82.4, 89.8, 89.9, 
101.6, 101.6, 102.2, 102.7, 102.7, 103.3, 103.3, 105.7, 105.8, 105.8, 114.1, 114.3, 114.5, 114.9, 114.9, 
115.3, 118.2, 118.5, 118.5, 119.3, 119.4, 119.8, 119.8, 130.7, 130.7, 131.5, 131.7, 132.1, 132.2, 132.2, 
132.3, 132.3, 132.3, 135.8, 135.9, 136.1, 136.2, 158.6, 158.6, 158.7, 158.9, 159.1, 159.1, 161.8 ppm. 





Compound 3a: 1H-NMR (400 MHz, CD3OD) 
 




















































































































































































Compound 4a: 1H-NMR (300 MHz, (CD3)2CO) 
 







































































































































































































































































Compound anti-3': 1H-NMR (400 MHz, CD3OD) 
 








































































































































Compound syn-3b'': 1H-NMR (300 MHz, CD3OD) 
 














































































































































































































































































































































Compound 3c: 1H-NMR (300 MHz, (CD3)2CO) 
























































































































































































































































Compound 4c: 1H-NMR (300 MHz, (CD3)2CO) 
 




















































































































































































































































































































































































Compound 3d: 1H-NMR (300 MHz, (CD3)2CO) 
 































































































































































































































































































































Compound 4d: 1H-NMR (300 MHz, (CD3)2CO) 
 




















































































































































































































































































Compound 3e: 1H-NMR (300 MHz, (CD3)2CO) 
 








































































































































































































































Compound 4e: 1H-NMR (300 MHz, (CD3)2CO) 
 

















































































































































































































































































































Compound 3f: 1H-NMR (300 MHz, (CD3)2CO) 
 











































































































































































































































Compound 4f: 1H-NMR (300 MHz, (CD3)2CO) 
 





















































































































































































































































































































Compound 3g: 1H-NMR (300 MHz, (CD3)2CO) 
 



































































































































































































































































Compound 4g: 1H-NMR (300 MHz, (CD3)2CO) 
 


























































































































































































































































































Compound 3h: 1H-NMR (400 MHz, (CD3)2SO) 
 

























































































































































































































































































































































































Compound 3i: 1H-NMR (300 MHz, (CD3)2CO) 
 



























































































































































































































Compound 4i: 1H-NMR (300 MHz, (CD3)2CO) 
 
















































































































































































































































































































Compound 3j: 1H-NMR (300 MHz, (CD3)2CO) 
 













































































































































































































































Compound 4j: 1H-NMR (300 MHz, (CD3)2CO) 
 






































































































































































































































































































































Compound 3k: 1H-NMR (300 MHz, (CD3)2CO) 
 




































Compound 4k: 1H-NMR (300 MHz, (CD3)2CO) 
 







































































Compound 3l: 1H-NMR (300 MHz, (CD3)2CO) 
 


























































Compound 4l: 1H-NMR (300 MHz, (CD3)2CO) 
 
 








































3 Determination ofisomers ratio 3 to 4 
3.1 1H-NMR spectrum of compound mixture 3a and 4a 
 


















































































































3.3 1H-NMR spectrum of compound mixture 3c and 4c 
 



































































































































































3.5 1H-NMR spectrum of compound mixture 3e and 4e 
 



























































































































3.7 1H-NMR spectrum of compound mixture 3g and 4g 
 



















































































































3.9 1H-NMR spectrum of compound mixture 3i and 4i 
 



































































































































3.11 1H-NMR spectrum of compound mixture 3k and 4k 
 















































































































































4 Mechanistic investigations using mass spectrometry 
4.1 Domino reaction between phenylacetaldehyde and malononitrile catalyzed by imidazole 
(16h20min reaction time) 
GC-MS spectrum measured on a Perkin Elmer GC-Clarus 680 and MS-Clarus SQ8C apparatus: 
 





4.2 Domino reaction between phenylacetaldehyde and malononitrile catalyzed by imidazole 














4.3 Domino reaction between phenylacetaldehyde and malononitrile catalyzed by imidazole  





5 X-ray crystallography 
5.1 X-ray crystallography of compound 3a' 
Experimental  
Single crystals of C25H18N6were crystallized from MeOD. A suitable crystal was selected and mounted 
on a loop on a SuperNova, Dual, Cu at zero, Atlas diffractometer. The crystal was kept at 173.15 K 
during data collection. Using Olex2 [1], the structure was solved with the ShelXS [2] structure solution 
program using Direct Methods and refined with the ShelXL [3] refinement package using Least Squares 
minimization. 
1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, OLEX2: a 
complete structure solution, refinement and analysis program. J. Appl. Cryst. (2009). 42, 339-
341. 
2. SHELXS, G.M. Sheldrick, Acta Cryst. (2008). A64, 112-122 
3. SHELXL, G.M. Sheldrick, Acta Cryst. (2008). A64, 112-122 
Crystal Data. C25H18N6, M =402.45, monoclinic, a = 17.810(4) Å, b = 9.2309(3) Å, c = 23.679(5) Å, 
β = 147.50(5)°, V = 2091.4(6) Å3, T = 173.15, space group P21/n (no. 14), Z = 4, μ(Mo Kα) = 0.080, 
6416 reflections measured, 3689 unique (Rint = 0.0399) which were used in all calculations. The final 
wR2 was 0.1283 (all data) and R1 was 0.0478 (>2sigma(I)).  
CCDC 991547 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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5.3 X-ray crystallography of compound 3b' 
 
Experimental  
Single crystals of C15H14N6were crystallized from THF and cyclohexane. A suitable crystal was selected 
and mounted on a loop on a SuperNova, Dual, Cu at zero, Atlas diffractometer. The crystal was kept at 
173.16 K during data collection. Using Olex2 [1], the structure was solved with the ShelXS [2] structure 
solution program using Direct Methods and refined with the ShelXL [3] refinement package using Least 
Squares minimization. 
1. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, OLEX2: a 
complete structure solution, refinement and analysis program. J. Appl. Cryst. (2009). 42, 339-
341. 
2. SHELXS, G.M. Sheldrick, Acta Cryst. (2008). A64, 112-122 
3. SHELXL, G.M. Sheldrick, Acta Cryst. (2008). A64, 112-122 
Crystal Data.C15H14N6, M =278.32, monoclinic, a = 8.20751(17) Å, b = 14.2238(3) 
Å, c = 12.7530(3) Å, β = 95.703(2)°, V = 1481.44(5) Å3, T = 173.1(6), space group P21/n (no. 14), 
Z= 4, μ(Cu Kα) = 0.647, 6640 reflections measured, 2276 unique (Rint = 0.0366) which 
wereusedinall calculations. The final wR2 was 0.1324 (all data) and R1 was 0.0453 (I >2\s(I)). 
CCDC 1435950 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
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6 Catalyst Screening 








7 Mechanistic investigations using DFT methods in conjunction with semiempirical van der 
Waals interactions 
 
Computational details  
 
The DFT study was performed with the TURBOMOLE program package [1]. The PBE density 
functional [2] was used throughout. In case of the thermodynamic study (data presented in Figure 4 of 
the main paper) of the reaction the def2-TZVP basis set [3] was applied, in case of the kinetic study 
(data presented in Figure 5 of the main paper) the geometries were first optimized applying the def2-
TZVP basis set and afterwards re-optimized using the more diffuse aug-cc-pVTZ basis set [4] to account 
for the anionic nature of some of the species involved in the reactions. The resolution of identity 
approximation [5] in conjunction with the multipole approximation[6], which greatly speeds up the 
calculations without sacrifying accuracy, was used for all calculations. Since the species involved in the 
reaction contain many aryl-groups and double bonds we expected dispersion interactions to play an 
important role for the thermodynamic and kinetics of the studied reaction and therefore we included 
dispersion interactions in form of the semi-empiric dispersion interaction correction established by the 
group of S. Grimme [7] in all calculations. All energies refer to the Gibbs free energies ΔG obtained 














[1] Turbomole 6.5 and 6.6, a development of University of Karlsruhe and Forschungszentrum Karlsruhe GmbH, 1989-2007, 
Turbomole GmbH, since 2007; available from www.turbomole.com 
[2] J. P. Perdew, K. Burke,M. Ernzerhof, Phys. Rev. Lett.1996, 77, 3865–3868. 
[3] F. Weigend, R. Ahlrichs, Phys. Chem. Chem. Phys.2005, 7, 3297–3305. 
[4] a) T.H. Dunning, Jr. J. Chem. Phys.1989, 90, 1007-1023. b) D. Feller, J. Comp. Chem.1996,17, 1571-1586. c) K.L. 
Schuchardt, B.T Didier,T. Elsethagen, L. Sun, V. Gurumoorthi, J. Chase, J. Li, and T.L. Windus, J. Chem. Inf. Model., 
2007, 47, 1045-1052. 
[5] a) K. Eichkorn, O. Treutler, H. Öhm, M. Häser, R. Ahlrichs, Chem. Phys. Letters1995, 240, 283-290 and Chemical Physics 
Letters 1995, 242, 652-660. b) K. Eichkorn, F. Weigend, O. Treutler, R. Ahlrichs, Theo. Chem. Acc.1997, 97, 119-124. 
[6] M. Sierka, A. Hogekamp, R. Ahlrichs, J. Chem. Phys.2003, 118, 9136-9148 







Molecule 6 contains two chiral centers (see Fig. 7, main text) which remain unchanged during the 
reaction. From the crystal structure of 3a'(Fig. 5 main text)and a structure solution of 4a (see page 48 
of this SI) it has been deduced that the absolute configuration is RR (the enantiomeric SS configuration 
is of course also in the reaction mixture but all products possible from this configuration are 
enantiomeric to the one obtained from the RR reactant and have therefore the same energies). Unlike 
molecule 8, structure 7 possesses an additional chiral center (labeled 3 in Fig S1). Since both the R and 
S diastereomer (7-R and 7-S) can yield product 3a as the intramolecular addition (see Fig. 7, main  text) 
occurs via a planar allyl system both enantiomers have been taken into account. 
All species contain various single bonds which allow a large number of conformers. To obtain the most 
stable conformer, the following procedure has been used: First all nine possible staggered conformers 
of 6 obtained by rotating around bond 1 and 2 (s. Figure S1 and 2 for all bond labels) were calculated. 
For the six energetically lowest conformations found in this way(entry 2-4,6,7,10 in Table S1), the 
corresponding molecules 8, 7-R and 7-S were optimized with an individual starting configurations of 
the other labeled bonds in Figs. S1 and S2. The next step was to systematically rotate around the other 
labeled bonds for the two most stable conformers found this way. After the best conformation of one 
bond was found, the rotation around the next bond was checked while keeping the already optimized 
bond configurations. In case of 8 the bonds m1 and m2 were optimized simultaneously (4 configurations 
were studied: both H-Atoms of the CH(CN)2-group pointing inwards, both pointing outwards and one 
pointing outwards and one inwards (2 structures)). In addition, various other promising conformations 
have been calculated. However, it cannot be ruled out that more stable conformations exist. 
 
 
 Fig. S1: figure of 7-S (entry 1) with bonds and Fig. S2: figure of 8 (entry 1) with bonds and 









Table S1: Free energies of the conformers of 6 relative 
to conformer #1 of 6 
Table S2: Free energies of the conformers of 8 relative to 
conformer #1 of 6 

























































Table S3: Free energies of the conformers of 7-S 
relative to conformer #1 of 6 
Table S4: Free energies of the conformers of 7-R relative 
to conformer #1 of 6 




























































Kinetic study  
 
In order to study the kinetics of the branching point (“chemoselective step”) a transition state search for 
the Michael(68) and the nucleophilic addition(67)pathway with imidazole as catalyst was 
conducted. Starting from promising guesses obtained from previous TS searches or from screening the 
reaction coordinate with the bond length of the forming bond fixed at various distances, a TS was 
obtained by the TS search implemented in TURBOMOLE. The TSs found by this procedure were 
checked by visualizing the normal mode corresponding to the imaginary frequency, and by following 
this reaction coordinate in both directions (which lead after a geometry optimization to the reactant 
complex and intermediate/product complex associated with the studied reaction). The reactant 
complexes contain deprotonated malononitrile, the imidazolium cation and molecule 6. In case of the 
Michael reaction, deprotonated 8 is formed as intermediate at first. The product complex was finally 
obtained by protonating the intermediate and positioning imidazole close to this proton and optimizing 
the geometry.  
Usually, the energetically lowest TSs are not connected with the most stable conformers. For the 
nucleophilic addition reaction(67) the lowest lying TS contains 6 in form of the conformer #5 and 
leads to 7-S in form of the conformer #11. In case of the Michael reaction the lowest lying TS contains 
6 in form of the conformer #4 and leads to 8 in form of the conformer #2. The TSs presented here are 
only exemplary because many conformations of the reactant/product could lead to the lowest lying TSs, 
and for each of these TSs several possible orientations of the imidazolium cation exist. The free energies 
relative to the reactants of the nucleophilic addition(67)and Michael addition(68)reactions, 
respectively, are tabulated in Tables S5 and S6. 
 
Table S5: Free energies of the imidazole catalysed 
nucleophilic addition reaction(67) 
relative to the sum of conformer #1 of 6, 
imidazole and malononitrile 
Table S6: Free energies of the imidazole catalysed 
Michael reaction(68) relative to the sum of 
conformer #1 of 6, imidazole and 
malononitrile 

























The structure of the optimized reactant complex and product complex of the nucleophilic addition 
reaction is shown in Figure S3 and S4. The structure of the optimized reactant complex, the intermediate 














 Fig. S3: the optimized structure of the reactant complex Fig. S4: the optimized structure of the product complex






















 Fig. S5: the optimized structure of the reactant complex Fig. S6: the optimized structure of the intermediate 





















 Fig. S7: the optimized structure of the product complex  





Influence of dispersion interactions 
 
The influence of dispersion interactions on the thermodynamics (Figure 4 of the main paper) has been 
studied by re-optimizing the six most stable conformers of each species (6, 7-S, 7-R and 8) without 
applying the dispersion interaction corrections. The free energies relative to the conformer 1 of 6 are 
summarized in Table S7-S10. The conformers have the same numbering as in Table S1-4 but are sorted 
energetically. Figure S8 is Figure 8 of the main paper using energies without dispersion corrections. 
Table S7:  
Free energies of the conformers of 6 relative to  
conformer #1 of 6 without dispersion interaction 
Table S8:  
Free energies of the conformers of 8 relative to  
conformer #1 of 6 without dispersion interaction 
 
















Table S9:  
Free energies of the conformers of 7-Srelative  
to conformer #1 of 6 without dispersion interaction 
Table S10:  
Free energies of the conformers of 7-Rrelative  
to conformer #1 of 6 without dispersion interaction 



















Fig. S8: without dispersion interaction correction;  
Energies (in kcal/mol) (see also for comparison Figure 8 of the main paper) 
 
The influence of dispersion interactions on the kinetics was estimated by subtracting the dispersion 
correction given in the TURBOMOLE output from the SCF-energies. No reoptimization was done in 
this case since these recalculations would be much more expensive in case of TS searches. The free 
energies obtained this way are presented in Table S11 and S12. 
 
Table S11:  
Free energies of the imidazole catalysed  
nucleophilic addition reaction relative to the sum of  
conformer #1 of 6, imidazole and  
malononitrile without dispersion interactions 
Table S12:  
Free energies of the imidazole catalysed  
Michael reaction relative to the sum of  
conformer #1 of 6, imidazoleand malononitrile  
without dispersion interactions 




















product  17.84 
 
